Mode of administration of international prostate symptom score in patients with lower urinary tract symptoms: Physician vs self

Prostate Cancer and Prostatic Diseases

Volumn 7, Issue 1, 2004, Pages 41-44

  Cam, Kamil ^a   Akman, Y ^a   Cicekci, B ^a   Senel, F ^a   Erol, A ^a  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

Author keywords

Benign prostatic hyperplasia; Diagnosis; Symptom score

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DOCTOR PATIENT RELATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUESTIONNAIRE; SCORING SYSTEM; SELF REPORT; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; URINARY TRACT DISEASE;

AGED; HUMANS; MALE; MIDDLE AGED; OBSERVER VARIATION; PATIENT EDUCATION; PHYSICIAN-PATIENT RELATIONS; PROSTATIC HYPERPLASIA; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 1842477354     PISSN: 13657852     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500683     Document Type: Article

References (16)

1. Bruskewitz R. Management of symptomatic BPH in US: Who is treated and how? Eur Urol 1999; 36: 7-13.
2. Roehrborn CG. The newly established guidelines for the diagnosis and management of benign prostatic hyperplasia. Curr Opin Urol 1995; 5: 30-35.
3. Mebust WK, Holtgrewe HL, Cocked ATK, Peter PC and Writing Committee. Transurethral prostatectomy: Immediate and post-operative complications. A cooperative study of thirteen participating institutions evaluating 3,885 patients. J Urol 1989; 141: 243-253.
4. McConnell JD. Epidemiology, etiology, pathophysiology, and diagnosis of benign prostatic hyperplasia. In: Walsh PC, Retik AB, Vaughan Jr ED and Wein AJ (eds). Campbell's Urology, 7th edn. WB Saunders Company: Philadelphia, PA, 1998, pp 1429-1452.
5. Barry MJ et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol 1992; 148: 1549-1557.
6. Jepsen JV, Bruskewitz RC. Comprehensive patient evaluation for benign prostatic hyperplasia. Urology 1998; 51(4A Suppl): 13-18.
7. Jepsen JV, Bruskewitz RC. Office evaluation of men with lower unnary tract symptoms. Urol Clin North Am 1998; 25: 545-554.
8. Lujan Galan M et al. The validity of the IPSS questionnaire in a sample of 262 patients with benign prostatic hyperplasia. Arch Esp Urol 1997; 50: 847-853.
9. MacDiarmid SA et al. An assessment of the comprehension of the American Urological Association Symptom Index. J Urol 1998; 159: 873-874.
10. Gee WF et al. 1997 American Urological Association Gallup Survey: Changes in diagnosis and management of prostate cancer and benign prostatic hyperplasia, and other practice trends from 1994-1997. J Urol 1998; 160: 1804-1807.
11. Netto Jr NR et al. Latin American study on patient acceptance of the International Prostate Symptom Score (IPSS) in the evaluation of symptomatic benign prostatic hyperplasia. Urology 1997; 49: 46-49.
12. Russo F et al. International prostate symptom score: comparison of doctor and patient. Arch Ital Urol Androl 1998; 70: 15-24.
13. Cockett ATK. Editorial comment: Symptom score in patients with benign prostatic hyperplasia. J Urol 1996; 155: 1959.
14. Cam K, Senel F, Akman Y, Erol A. The efficacy of an abbreviated model of International Prostate Symptom Score in evaluating benign prostatic hyperplasia. BJU Int 2003; 91: 186-189.
15. Plante M et al. The international prostate symptom score: physician versus self-administration in the quantification of symptomatology. Urology 1996; 47: 326-328.
16. Netto Jr NR, de Lima ML. The influence of patient education level on the international prostatic symptom score. J Urol 1995; 154:97-99.